Article Text

PDF
AB0440 Impact of vitamin d deficiency upon disease activity and immune disorder in rheumatoid arthritis patients
  1. Y Liu,
  2. HY Wen
  1. Rheumatology, the Second Hospital of Shanxi Medical University, Taiyuan, China

Abstract

Background Emerging evidence suggests that vitamin D plays an important role in immune regulation.

Objectives The objective of this work was to determine if patients with rheumatoid arthritis (RA) are at risk for vitamin D deficiency and whether vitamin D levels correlate with disease activity or immune disorders.

Methods This study was a retrospective research. RA patients who had vitamin D levels and immune function indexes of each other were included. Patients receiving or have received vitamin D, corticosteroids, disease-modifying anti-rheumatic drugs or a tumor necrosis factor antagonist and those who had hepatic or renal insufficiency were excluded. Multivariate analysis was performed to examine correlations and control for confounding factors.

Results As suggested threshold (≤25 ng/ml), the overall prevalence of vitamin D insufficiency was 265 of 280 (94.8%). Mean serum vitamin D insufficiency levels of 11.15±4.74 ng/ml for RA patients were significantly lower compared to controls (31.62±6.46) (p=0.001). Among all the subjects, 208 (72.7%) were females. Vitamin D levels in high disease activity group were lower compared to vitamin D level in patients with low and moderate disease activity (DAS-28 score >5.1, 3.2–5.1, <3.2, respectively, p<0.001) and vitamin D levels had an inverse correlation with DAS28 score (β-coefficient-0.164, p=0.018, per 1 ng/ml). In patients with RA, the levels of vitamin D were moderately and inversely associated with Th 17 (β-coefficient-0.158, p=0.019, per 1 ng/ml). However, no significant relationship was found between vitamin D and these variables (T cell, B cell, NK cell, Treg, Th1, Th2, Th17/Treg) in patients.

Table 1.

Disease activity, immune function indexes with RA as mean ± standard deviation or number (%) for total group and based on vitamin D status

Table 2.

Multivariate associations of serum 1,25(OH)2 D3 concentrations with RA (n=280)

Conclusions Lower levels of vitamin D are associated with worse DAS28 and higher levels of Th17 with RA, especially in female patients. The levels of 1,25-dihydroxycholecalciferol (1,25(OH)2D3) could be a marker to monitor the disease activity in RA patients and vitamin D may be an alternative supplementary treatment for RA.

Acknowledgements This work was supported by research grants from the National Natural Science Foundation of China (no. 81301532/H0603) and the Shanxi Science and Technology research projects of China (no. 201603D321074).

Disclosure of Interest None declared

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.